Social Impact of Hepatic Encephalopathy.

Activities of Daily Living Automobile Driving Caregivers / economics Employment Gastrointestinal Agents / therapeutic use Hepatic Encephalopathy / complications Humans Lactulose / therapeutic use Quality of Life Rifaximin / therapeutic use Sleep Wake Disorders / etiology
Caregiver Driving Finance Quality of life Sleep Social impact

Journal

Clinics in liver disease
ISSN: 1557-8224
Titre abrégé: Clin Liver Dis
Pays: United States
ID NLM: 9710002

Informations de publication

Date de publication:
05 2020
Historique:
entrez: 5 4 2020
pubmed: 5 4 2020
medline: 20 7 2021
Statut: ppublish

Résumé

Hepatic encephalopathy (HE) is a multifaceted disorder, with effects stretching far beyond office visits and hospitalizations. Patients with HE suffer from varying degrees of altered consciousness, intellectual disability, and personality changes. A large social impact exists for patients with HE. Quality of life and activities of daily living, such as work capacity, driving ability, and sleep quality, have been shown to be affected. Additionally, caregiver and financial burdens are highly prevalent. Multiple tools exist to assess quality of life, including the CLD-Q questionnaire. Common treatments for HE, including rifaximin and lactulose, have been shown to improve overall quality of life.

Identifiants

DOI: 10.1016/j.cld.2020.01.008 PMID: 32245534
pubmed: 32245534
pii: S1089-3261(20)30008-8
doi: 10.1016/j.cld.2020.01.008
pii:
doi:

Substances chimiques

Gastrointestinal Agents 0
Lactulose 4618-18-2
Rifaximin L36O5T016N

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

291-301

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Disclosures The authors have nothing to disclose.

Auteurs

Mishal Reja (M)

Department of Medicine, Rutgers Robert Wood Johnson University Hospital, Clinical Academic Building (CAB), 125 Paterson Street, Suite 5100B, New Brunswick, NJ 08901, USA. Electronic address: dr845@rwjms.rutgers.edu.

Lauren Pioppo Phelan (LP)

Department of Medicine, Rutgers Robert Wood Johnson University Hospital, Clinical Academic Building (CAB), 125 Paterson Street, Suite 5100B, New Brunswick, NJ 08901, USA.

Frank Senatore (F)

Department of Gastroenterology, Rutgers Robert Wood Johnson University Hospital, Clinical Academic Building, 125 Paterson Street, Suite 5100B, New Brunswick, NJ 08901, USA.

Vinod K Rustgi (VK)

Center for Liver Diseases and Masses, Robert Wood Johnson Medical School, Clinical Academic Building (CAB), 125 Paterson Street, Suite 5100B, New Brunswick, NJ 08901, USA. Electronic address: vr262@rwjms.rutgers.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Établissements, main d'oeuvre et services de soins de santé › Services de santé › Réadaptation › Activités de la vie quotidienne › Social Impact of Hepatic Encephalopathy.
questionsmedicales.fr › Activités humaines › Conduite automobile › Social Impact of Hepatic Encephalopathy.
questionsmedicales.fr › Établissements, main d'oeuvre et services de soins de santé › Personnel de santé › Aidants › Social Impact of Hepatic Encephalopathy.
questionsmedicales.fr › Caractéristiques de la population › Facteurs socioéconomiques › Emploi › Social Impact of Hepatic Encephalopathy.
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Agents gastro-intestinaux › Social Impact of Hepatic Encephalopathy.
questionsmedicales.fr › Maladies métaboliques et nutritionnelles › Maladies métaboliques › Encéphalopathies métaboliques › Encéphalopathie hépatique › Social Impact of Hepatic Encephalopathy.
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Social Impact of Hepatic Encephalopathy.
questionsmedicales.fr › Glucides › Sucres › Diholoside › Lactulose › Social Impact of Hepatic Encephalopathy.
questionsmedicales.fr › Environnement et santé publique › Santé publique › Mesures épidémiologiques › Démographie › État de santé › Qualité de vie › Social Impact of Hepatic Encephalopathy.
questionsmedicales.fr › Composés polycycliques › Composés macrocycliques › Lactames macrocycliques › Rifamycine › Rifaximine › Social Impact of Hepatic Encephalopathy.
questionsmedicales.fr › Troubles mentaux › Troubles de la veille et du sommeil › Social Impact of Hepatic Encephalopathy.